$66
Availability
In stock
Last checked
1 hour ago
A synthetic long-acting analog of glucagon-like peptide-1 (GLP-1).
Observed median price
$160
7
Active listings
4 · 99.6%
Independent lab tests
$66–$200
Observed price range
5
Known aliases
Read from the certificate, not re-measured by VialGrade.
Understand this compound
The GLP-1 analog behind Ozempic and Wegovy — the most-searched compound in weight and metabolic research.
Good to know: GI side effects (nausea, vomiting) are common in trials, and long-term safety of non-pharmaceutical-grade research material is unverified and unregulated.
A GLP-1 receptor agonist; mimics the endogenous incretin hormone GLP-1 to stimulate glucose-dependent insulin secretion, suppress glucagon, slow gastric emptying, and signal satiety via hypothalamic GLP-1 receptors.
Mechanism of action from published research — how the molecule behaves, not a claim about any product or any human-use effect.
Studied for glycemic control in type-2 diabetes and for chronic weight management, with further research into cardiovascular risk reduction, MASH/liver fat, and addiction/reward pathways.
FDA-approved (for type-2 diabetes and obesity); approved as Ozempic/Rybelsus for type-2 diabetes and Wegovy for chronic weight management.
Where the science stands — an approved drug is not the same as the research-grade material a vendor sells, which is unregulated regardless.
Research context only — VialGrade never gives dosing, medical, or human-use guidance.
This is a prescription drug in the US
This is the active drug in Ozempic and Wegovy — an FDA-approved prescription medication. Buying a “research” version sidesteps the prescription requirement and the approved, quality-controlled supply chain. The FDA has warned about and acted against unapproved and compounded copies. Higher legal and safety exposure than an unapproved research peptide.
Read the full US legal overview →General information, not legal or medical advice. VialGrade sells nothing and encourages no human use.
Reference source
Semaglutide is the active ingredient in FDA-approved medicines made by Novo Nordisk (Ozempic, Wegovy, Rybelsus). Grey-market “Semaglutide” sold for research is not Novo Nordisk’s product and is not the FDA-approved drug — a different, unregulated supply chain under the same chemical name. See what pharmaceutical-grade means →
Compare by real cost
Vials come in different sizes, so the sticker price lies. This ranks every listing by what a milligram actually costs — with independent test purity where we have it.
| # | Vendor | Size | Price | Per mg | Tested purity | Real $/active mg | |
|---|---|---|---|---|---|---|---|
| 1 | Umbrella Labs | 210mg total30 Tablets (7mg/tablet) each | $160 | $0.76/mg · too cheap? | — | $0.76/mgbest value | View |
| 2 | Umbrella Labs | 15mg total | $200 | $13.3/mg | — | $13.4/mg | View |
| 3 | Umbrella Labs | 10mg total | $180 | $18.0/mg | — | $18.1/mg | View |
| 4 | Umbrella Labs | 5mg total | $100 | $20.0/mg | — | $20.1/mg | View |
| 5 | Nootropic Source | 6mg total | $160 | $26.7/mg | — | $26.8/mg | View |
| 6 | Nootropic Source | 3mg total | $90 | $30.0/mg | — | $30.1/mg | View |
Real $/active mg divides the price-per-mg by the measured purity — the honest cost of the actual peptide, so a 90%-pure vial isn’t compared as if it were 99%. Too cheap? flags a listing far below the market rate — often underdosing or a fake, not a deal. The crown marks the cheapest non-outlier; best value marks the lowest real cost per active mg.
Current market
$66
Availability
In stock
Last checked
1 hour ago
$90
$30.0/mg
+58% vs median/mg
Availability
In stock
Last checked
51 minutes ago
$100
$20.0/mg
+5% vs median/mg
Availability
In stock
Last checked
1 hour ago
$160
$0.76/mg
-96% vs median/mg
Availability
In stock
Last checked
1 hour ago
$160
$26.7/mg
+40% vs median/mg
Availability
In stock
Last checked
51 minutes ago
$180
$18.0/mg
-5% vs median/mg
Availability
In stock
Last checked
1 hour ago
$200
$13.3/mg
-30% vs median/mg
Availability
In stock
Last checked
1 hour ago
Commonly researched together
Compounds the research community frequently discusses alongside Semaglutide. Not a protocol or a recommendation — a starting point for what to read about next.
Independent testing
Real, publicly verifiable third-party tests. Purity is read from the certificate itself. A test reflects one lab’s result for one submitted batch — not a guarantee that every vial matches.
Every record below is a real certificate of analysis, gathered two ways: from the public verification feeds that independent labs (like Janoshik) publish, and from the certificates vendors post on their own product pages. We open each certificate document and read the measured purity, content, batch, and date directly off it — a scraper can’t read a number printed inside an image, so this is done by machine vision, then recorded here with a link back to the original.
Nothing here is typed in by a vendor or invented by us. Where a certificate is missing, we say so rather than filling the gap.
We re-check the lab feed, too. A “still listed” tag means the certificate is currently public in Janoshik’s database — we re-verify against the live feed and stamp the date. If a cert is later pulled, the tag flips. It’s a freshness check on the same source, not a second independent opinion.
Three different questions. Purity (“how clean?”), identity (“is it the right molecule?”, a mass-spec test), and content (“did I get the labeled mg?”) are separate. A vial can be 99% pure and still be the wrong peptide, or the right peptide underdosed. We flag the measured dose against the label above; underdosing is the most common real fraud.
Who submitted the sample matters. Most of these are vendor-submitted — the seller chose which vial to send, so one good certificate doesn’t prove every batch is the same. The gold standard is a blind test, where a buyer sends a vial they bought as a normal customer. Same label doesn’t prove same product; same batch number doesn’t prove same batch.
2
blind tests
99.9%
highest tested purity
| Certificate | Manufacturer | Batch | Purity | Content / dose | Lab | |
|---|---|---|---|---|---|---|
| Alpha BioPharma Blind | BBSXADDG | 99.89% | 10.10 mg | Janoshik Analytical Still listed | Verify | |
| www.certapeptides.com Blind | CP-2604-SEM5 | 99.26% | 5.23/5mg · full | Janoshik Analytical Still listed | Verify | |
| Simple Peptide | 20240604 | 99.81% | — | Freedom Diagnostics Testing | Verify | |
| Peptide Pros | 2023-06-22 | 99.40% | — | MZ Biolabs | Verify |
Tested batches
The full test history for one batch — who picked the sample, who tested it, and what came back. It describes the vials that were tested, never every vial they sold.
Research summaries describe published literature and market data only. They do not establish the identity, quality, safety, or legal status of any listed physical product.